{
  "name": "Amgen",
  "slug": "amgen",
  "ticker": "AMGN",
  "fetched_at": "2025-10-06T12:22:55.277327+00:00",
  "news": [
    {
      "title": "Amgen says its cholesterol shot prevented heart problems in a broad population - statnews.com",
      "link": "https://news.google.com/rss/articles/CBMifEFVX3lxTFB6eHRrODN6bEVMcGhBNU5IQk5RRmZENjRCVDJWRkZCS1RtMThXQ0JFZjVDd2c4MmFleFVpWDdYRVRjLTJjNGhUVjMtbU1xUlBsalVRQlFkZzdXSFR4eU9nZDBMMVVabFRWbGdEdVZEWjRHUm52Q2NfY0dwLTA?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMifEFVX3lxTFB6eHRrODN6bEVMcGhBNU5IQk5RRmZENjRCVDJWRkZCS1RtMThXQ0JFZjVDd2c4MmFleFVpWDdYRVRjLTJjNGhUVjMtbU1xUlBsalVRQlFkZzdXSFR4eU9nZDBMMVVabFRWbGdEdVZEWjRHUm52Q2NfY0dwLTA?oc=5\" target=\"_blank\">Amgen says its cholesterol shot prevented heart problems in a broad population</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">statnews.com</font>",
      "published": "2025-10-02T13:04:07+00:00",
      "source": "statnews.com"
    },
    {
      "title": "Amgen claims ‘landmark’ study result that could widen heart drug’s use - BioPharma Dive",
      "link": "https://news.google.com/rss/articles/CBMinwFBVV95cUxNcTBRWWJKa1BpLTBIZDNyaUJGSTFLVkMyZ3EyRV9USWlPME94S1MyNHhqczJ5ODR1SFFyZFZaQmRYdHBRcEFBRXFEa2FrY3JGSDhEMjNmZnZrYkw2MXZyU01qaGptalg0V0std3NNLXdnaTJyZWtMTWl3d0NncFlCUmstQzlfVUlwUk4yazNOeXhEa3J5Z1JvSElSSjdQNlk?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMinwFBVV95cUxNcTBRWWJKa1BpLTBIZDNyaUJGSTFLVkMyZ3EyRV9USWlPME94S1MyNHhqczJ5ODR1SFFyZFZaQmRYdHBRcEFBRXFEa2FrY3JGSDhEMjNmZnZrYkw2MXZyU01qaGptalg0V0std3NNLXdnaTJyZWtMTWl3d0NncFlCUmstQzlfVUlwUk4yazNOeXhEa3J5Z1JvSElSSjdQNlk?oc=5\" target=\"_blank\">Amgen claims ‘landmark’ study result that could widen heart drug’s use</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">BioPharma Dive</font>",
      "published": "2025-10-02T16:07:34+00:00",
      "source": "BioPharma Dive"
    },
    {
      "title": "Merit Financial Group LLC Has $6.79 Million Stake in Amgen Inc. $AMGN - MarketBeat",
      "link": "https://news.google.com/rss/articles/CBMixAFBVV95cUxQSjBCTFpIMF91V0VwbnBnNks3R1EwUC01OE9XYk01VERaeTduSkpiTW5tV1pyNERsemxGZGxQYXBUeFpWNmU4bVFYYlAtMHlIall4WkxsdzlvQ3ZEZDF5QU51UjlhVTRPR1dNMzhyT1p1bjNfWm8ybUNJZDNRR055SnRPV0g4NzRZWlZTOUYtSF9uX2Q0UU8tOWdIRVZSeDQ3Z3pWN2lKQmIxMzgwa0RZVS11SlYxd2JBUVhFMnRNUnNiVkRm?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMixAFBVV95cUxQSjBCTFpIMF91V0VwbnBnNks3R1EwUC01OE9XYk01VERaeTduSkpiTW5tV1pyNERsemxGZGxQYXBUeFpWNmU4bVFYYlAtMHlIall4WkxsdzlvQ3ZEZDF5QU51UjlhVTRPR1dNMzhyT1p1bjNfWm8ybUNJZDNRR055SnRPV0g4NzRZWlZTOUYtSF9uX2Q0UU8tOWdIRVZSeDQ3Z3pWN2lKQmIxMzgwa0RZVS11SlYxd2JBUVhFMnRNUnNiVkRm?oc=5\" target=\"_blank\">Merit Financial Group LLC Has $6.79 Million Stake in Amgen Inc. $AMGN</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">MarketBeat</font>",
      "published": "2025-10-06T09:08:43+00:00",
      "source": "MarketBeat"
    },
    {
      "title": "Global biotech leaders Amgen and Gilead announcing expansions in California, the #1 state for life sciences - CA.gov",
      "link": "https://news.google.com/rss/articles/CBMi1wFBVV95cUxQNkFQNVUxYWlJQU1YZlpBSXFrUEotWnBHU1hEQ0lmcU0wR25nX3hETGkxV2M2UVN5NW5ZNHdjYS03NVAyUTBWVjJIZkRyUmR3cXBfUVFjUHVDWDFhYlZSTEhqTlFyenIyNXphZXcyVzNLMml4dlhxeG1qa1dWck1uY1J0SmdaeW9NQ3JmOHNZcnpBR1V2cVAyaXZIXzcxYkFWR3FyTi01NWtFaGE4WGZtbFRlOEQ2ajFJdGpRQ2FDbnBXd3RwbVZob2lJQzZVQWVXOU9VWkxscw?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMi1wFBVV95cUxQNkFQNVUxYWlJQU1YZlpBSXFrUEotWnBHU1hEQ0lmcU0wR25nX3hETGkxV2M2UVN5NW5ZNHdjYS03NVAyUTBWVjJIZkRyUmR3cXBfUVFjUHVDWDFhYlZSTEhqTlFyenIyNXphZXcyVzNLMml4dlhxeG1qa1dWck1uY1J0SmdaeW9NQ3JmOHNZcnpBR1V2cVAyaXZIXzcxYkFWR3FyTi01NWtFaGE4WGZtbFRlOEQ2ajFJdGpRQ2FDbnBXd3RwbVZob2lJQzZVQWVXOU9VWkxscw?oc=5\" target=\"_blank\">Global biotech leaders Amgen and Gilead announcing expansions in California, the #1 state for life sciences</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">CA.gov</font>",
      "published": "2025-09-15T07:00:00+00:00",
      "source": "CA.gov"
    },
    {
      "title": "Amgen charts late-stage win for Repatha in broad cardiovascular risk population - Fierce Pharma",
      "link": "https://news.google.com/rss/articles/CBMirAFBVV95cUxNcmI0RVctcnRyc09Cc2xWWnItamE1QjFtV1o3MWpIMTI3REZUOG9QZENCR2F0dUF2eHdCQ3JHUF9McGdVY2w3akwxc0EtRzNlZHUyTUx4Q3pCM1hTbjNGZlBDLVpVeXl0RHJRNG9vNGVxTlltWVhwWnlkZHM4TGY0Ym5LdGhnZGw3ZTE3T1lwQmRCRTFlOHVkV1ZRclZwUktMM0p1VTVoZ2V5MXhf?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMirAFBVV95cUxNcmI0RVctcnRyc09Cc2xWWnItamE1QjFtV1o3MWpIMTI3REZUOG9QZENCR2F0dUF2eHdCQ3JHUF9McGdVY2w3akwxc0EtRzNlZHUyTUx4Q3pCM1hTbjNGZlBDLVpVeXl0RHJRNG9vNGVxTlltWVhwWnlkZHM4TGY0Ym5LdGhnZGw3ZTE3T1lwQmRCRTFlOHVkV1ZRclZwUktMM0p1VTVoZ2V5MXhf?oc=5\" target=\"_blank\">Amgen charts late-stage win for Repatha in broad cardiovascular risk population</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Fierce Pharma</font>",
      "published": "2025-10-02T15:26:34+00:00",
      "source": "Fierce Pharma"
    },
    {
      "title": "LANDMARK PHASE 3 TRIAL (VESALIUS-CV) MEETS PRIMARY ENDPOINTS IN A CARDIOVASCULAR PRIMARY PREVENTION STUDY OF 12,000 PATIENTS - PR Newswire",
      "link": "https://news.google.com/rss/articles/CBMiigJBVV95cUxQZU1zbUE3cHVfcmtSejJmS0k4Zm9KNUNfR3k0eHRLR3AtWEh0OHRzWVhEdkNnUml6Q2d3YVpNdFlSRGRlY1J3NnFud1paSURsQS1HQ1lhZ243U2RzcG56WjRmTlBqR09TeklOajcyTTFDYVNGR1QxSHo1bUZzOGRfU0ducDFRbnpxZWxWTlhRaVNFclh4S3M0STdnbmhzeGRudlRRdFk0dndWdkJCTjlhSk5YQmJlWkNaeS0tUWhwQWlUbU10OXJqRGtWLVVrb3hKZHlScURzemJrVDZweFdrNHIyVUhYeHBJQW1SRFBpSU9hUlEtd0lqZzRJcGpMamNpSTJpdDhYU2VoZw?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMiigJBVV95cUxQZU1zbUE3cHVfcmtSejJmS0k4Zm9KNUNfR3k0eHRLR3AtWEh0OHRzWVhEdkNnUml6Q2d3YVpNdFlSRGRlY1J3NnFud1paSURsQS1HQ1lhZ243U2RzcG56WjRmTlBqR09TeklOajcyTTFDYVNGR1QxSHo1bUZzOGRfU0ducDFRbnpxZWxWTlhRaVNFclh4S3M0STdnbmhzeGRudlRRdFk0dndWdkJCTjlhSk5YQmJlWkNaeS0tUWhwQWlUbU10OXJqRGtWLVVrb3hKZHlScURzemJrVDZweFdrNHIyVUhYeHBJQW1SRFBpSU9hUlEtd0lqZzRJcGpMamNpSTJpdDhYU2VoZw?oc=5\" target=\"_blank\">LANDMARK PHASE 3 TRIAL (VESALIUS-CV) MEETS PRIMARY ENDPOINTS IN A CARDIOVASCULAR PRIMARY PREVENTION STUDY OF 12,000 PATIENTS</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">PR Newswire</font>",
      "published": "2025-10-02T13:00:00+00:00",
      "source": "PR Newswire"
    },
    {
      "title": "Amgen’s Phase III data supports FDA label expansion of Repatha - Clinical Trials Arena",
      "link": "https://news.google.com/rss/articles/CBMipgFBVV95cUxQR2I1ZThZZXRtSnJfemVpd1hiMldZMTBuUmZLT0FVSEd6bG1qdFJwdmJRQjNmXzdJSHMtalpidUpHUTlTdHVCeUlkZ2ZGSTZlZTUzREd4enpVemcydFQ2MnA1MHBLSjlpakNfVG1DazJUTVU5c0VhNFdGSWZmR285LXhKU3VKMGZUY2taUzFOaXVLVGxaTlp5UVJNc1BvVERXQklCcTRB?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMipgFBVV95cUxQR2I1ZThZZXRtSnJfemVpd1hiMldZMTBuUmZLT0FVSEd6bG1qdFJwdmJRQjNmXzdJSHMtalpidUpHUTlTdHVCeUlkZ2ZGSTZlZTUzREd4enpVemcydFQ2MnA1MHBLSjlpakNfVG1DazJUTVU5c0VhNFdGSWZmR285LXhKU3VKMGZUY2taUzFOaXVLVGxaTlp5UVJNc1BvVERXQklCcTRB?oc=5\" target=\"_blank\">Amgen’s Phase III data supports FDA label expansion of Repatha</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Clinical Trials Arena</font>",
      "published": "2025-10-03T11:03:45+00:00",
      "source": "Clinical Trials Arena"
    },
    {
      "title": "Amgen Employees Making a Difference on Land and Sea: 20 Years of Coastal Cleanup - Amgen",
      "link": "https://news.google.com/rss/articles/CBMiuwFBVV95cUxPUnozUm1uYVZOVDNMdkVzVXNnbTV1N2l2cmQzNi1DNjctcWJFZ3JQZUtyRFN5M0VfekNBN0UtaVRQY25hYURxNHI4NHJtQ3dHeE5BMzJNTGtydUtRNnlUUXZXMzR6Zy1tQ2hlZ3FUbVNqSkR0UjNCRTc0MFc3X0JRZlJHZVQxc3ZtdVlFdTNCR3ZjY3Q3djQ4eE5IWVF1Qm1JS3pZZnhoNnF3MU5oZnN3Um1XLTVEdVozeUhv?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMiuwFBVV95cUxPUnozUm1uYVZOVDNMdkVzVXNnbTV1N2l2cmQzNi1DNjctcWJFZ3JQZUtyRFN5M0VfekNBN0UtaVRQY25hYURxNHI4NHJtQ3dHeE5BMzJNTGtydUtRNnlUUXZXMzR6Zy1tQ2hlZ3FUbVNqSkR0UjNCRTc0MFc3X0JRZlJHZVQxc3ZtdVlFdTNCR3ZjY3Q3djQ4eE5IWVF1Qm1JS3pZZnhoNnF3MU5oZnN3Um1XLTVEdVozeUhv?oc=5\" target=\"_blank\">Amgen Employees Making a Difference on Land and Sea: 20 Years of Coastal Cleanup</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Amgen</font>",
      "published": "2025-09-29T23:00:59+00:00",
      "source": "Amgen"
    }
  ],
  "product_launches": [
    {
      "title": "Amgen, Kyowa Kirin Bolster Safety Profile for Atopic Dermatitis Hopeful - BioSpace",
      "link": "https://news.google.com/rss/articles/CBMisgFBVV95cUxQVEJYNkQ0cURCVTNSd1VIbU1JLWtmblBqXzNDZnp6SVBBcWpGcm5zNWdaUFZwdjN4aGR4TnJoYm9PMWk2STRNdmdKMjRKU2pQVURtamRpUDBja3ZhYk1ONHJRemdtdkpVRHJ3SXBESkdyNG1hMW1ZQW4wb0xpYmMxY0E5RkRyVERkaS1FczJlUmZmbVZRN2VWenB5czdkeFg4eG5jNkZqQm9RU3FaMjl6dl9R?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMisgFBVV95cUxQVEJYNkQ0cURCVTNSd1VIbU1JLWtmblBqXzNDZnp6SVBBcWpGcm5zNWdaUFZwdjN4aGR4TnJoYm9PMWk2STRNdmdKMjRKU2pQVURtamRpUDBja3ZhYk1ONHJRemdtdkpVRHJ3SXBESkdyNG1hMW1ZQW4wb0xpYmMxY0E5RkRyVERkaS1FczJlUmZmbVZRN2VWenB5czdkeFg4eG5jNkZqQm9RU3FaMjl6dl9R?oc=5\" target=\"_blank\">Amgen, Kyowa Kirin Bolster Safety Profile for Atopic Dermatitis Hopeful</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">BioSpace</font>",
      "published": "2025-09-10T07:00:00+00:00",
      "source": "BioSpace"
    },
    {
      "title": "Strong first-quarter product sales for Amgen - The Pharma Letter",
      "link": "https://news.google.com/rss/articles/CBMiggFBVV95cUxObE5kVHJ3TmlvdEhBTmplQjgtVEVfdE1LQ1hmcmw2UThFaTg4aVk4eEtMbjdPR0dabHBaM0dMczZ5MlB2QWlxaDBCcXh3ZkRDWFVpbVRDMjQxbXdNS2JrYzFQYWd5ZWw3S0ZEcGdGRTRKRFE3eWszOFFkX1A0QWpfdkxB?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMiggFBVV95cUxObE5kVHJ3TmlvdEhBTmplQjgtVEVfdE1LQ1hmcmw2UThFaTg4aVk4eEtMbjdPR0dabHBaM0dMczZ5MlB2QWlxaDBCcXh3ZkRDWFVpbVRDMjQxbXdNS2JrYzFQYWd5ZWw3S0ZEcGdGRTRKRFE3eWszOFFkX1A0QWpfdkxB?oc=5\" target=\"_blank\">Strong first-quarter product sales for Amgen</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">The Pharma Letter</font>",
      "published": "2025-05-02T07:00:00+00:00",
      "source": "The Pharma Letter"
    },
    {
      "title": "Amgen: Biosimilars And Rare Disease Pipeline Crucial To Overcome Patent Cliff Concerns - Seeking Alpha",
      "link": "https://news.google.com/rss/articles/CBMivwFBVV95cUxNNldFcDdyVUNrRFhsN2JMUDZuakRJNDN5R0JBNzFfbXNuaGVLVTRubVhsV3l2eEk4MGR2X2xLcXVON3NHVVZOVjZvZHNzdHBsTGVNZEFJaEp2WGRxUnNYdng4TS1yaWNrd1g5bW5tcnNvZUh1QzlleW96akRZUG1tNGRKLXdqdmg5TUdudlpielVzcHd2VUpYa3pfWkJjX0lESEJDc3BET1hFWGtreWdqNEdkNlMtT2dncThfMVVuOA?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMivwFBVV95cUxNNldFcDdyVUNrRFhsN2JMUDZuakRJNDN5R0JBNzFfbXNuaGVLVTRubVhsV3l2eEk4MGR2X2xLcXVON3NHVVZOVjZvZHNzdHBsTGVNZEFJaEp2WGRxUnNYdng4TS1yaWNrd1g5bW5tcnNvZUh1QzlleW96akRZUG1tNGRKLXdqdmg5TUdudlpielVzcHd2VUpYa3pfWkJjX0lESEJDc3BET1hFWGtreWdqNEdkNlMtT2dncThfMVVuOA?oc=5\" target=\"_blank\">Amgen: Biosimilars And Rare Disease Pipeline Crucial To Overcome Patent Cliff Concerns</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Seeking Alpha</font>",
      "published": "2025-07-15T07:00:00+00:00",
      "source": "Seeking Alpha"
    },
    {
      "title": "Amgen settles Prolia patent suit with Celltrion, teeing up potential biosimilar launch in June - Fierce Pharma",
      "link": "https://news.google.com/rss/articles/CBMiwwFBVV95cUxONkt3YUVEeUpwTU5LYVgtaTk2THhoMEt3ZUliWC1sWmhTTGR4M0hwaVpFMEFla01mUTdxbGVueWNGVThVT3U1T3R2NTQwaEkxeEI5MjRPMzVQUlhaU3hKNVVqQmFFY3BMQ2c3enphdTVLVy1Wb3dTb0l4Rnk3czFVTVFZbUdvVVJwa1I4Z3FDOFByVDZIV21Ccnk5VTd5U3VtNHhuVDdQUldHNm81YnZ6MHFReDBJNmk1S3BucTJhUlplcnc?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMiwwFBVV95cUxONkt3YUVEeUpwTU5LYVgtaTk2THhoMEt3ZUliWC1sWmhTTGR4M0hwaVpFMEFla01mUTdxbGVueWNGVThVT3U1T3R2NTQwaEkxeEI5MjRPMzVQUlhaU3hKNVVqQmFFY3BMQ2c3enphdTVLVy1Wb3dTb0l4Rnk3czFVTVFZbUdvVVJwa1I4Z3FDOFByVDZIV21Ccnk5VTd5U3VtNHhuVDdQUldHNm81YnZ6MHFReDBJNmk1S3BucTJhUlplcnc?oc=5\" target=\"_blank\">Amgen settles Prolia patent suit with Celltrion, teeing up potential biosimilar launch in June</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Fierce Pharma</font>",
      "published": "2025-01-28T08:00:00+00:00",
      "source": "Fierce Pharma"
    },
    {
      "title": "Amgen, Celltrion settle denosumab patent fight, enabling mid-year launch - FirstWord Pharma",
      "link": "https://news.google.com/rss/articles/CBMiU0FVX3lxTFBTNkxpQlV1QzhQeDRIVm1HSF9CNnBxbFBxVjBNWHNueVFjM0gwZHFLVkpxenNUZEV2Z0diSDVlZHJ1Wm9QVkdlTjJZUWNzTnlxLVR3?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMiU0FVX3lxTFBTNkxpQlV1QzhQeDRIVm1HSF9CNnBxbFBxVjBNWHNueVFjM0gwZHFLVkpxenNUZEV2Z0diSDVlZHJ1Wm9QVkdlTjJZUWNzTnlxLVR3?oc=5\" target=\"_blank\">Amgen, Celltrion settle denosumab patent fight, enabling mid-year launch</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">FirstWord Pharma</font>",
      "published": "2025-01-28T08:00:00+00:00",
      "source": "FirstWord Pharma"
    }
  ],
  "stock": {
    "ticker": "AMGN",
    "currency": "USD",
    "latest": {
      "date": "2025-10-03",
      "close": 297.8900146484375
    },
    "history": [
      {
        "date": "2025-09-25",
        "close": 271.17999267578125
      },
      {
        "date": "2025-09-26",
        "close": 272.9800109863281
      },
      {
        "date": "2025-09-29",
        "close": 273.9700012207031
      },
      {
        "date": "2025-09-30",
        "close": 282.20001220703125
      },
      {
        "date": "2025-10-01",
        "close": 298.5
      },
      {
        "date": "2025-10-02",
        "close": 297.3999938964844
      },
      {
        "date": "2025-10-03",
        "close": 297.8900146484375
      }
    ],
    "name": "Amgen Inc."
  }
}